| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.12.23 | Nano Dimension - Outlining the path to profitabililty | 423 | Edison Investment Research | Nano Dimension reported Q323 year-on-year revenue growth of 21.6%, an adjusted gross margin of 48.0% (+20.4pp y-o-y) and an adjusted EBITDA loss of $30.1m. Despite the Israeli/Palestinian conflict,... ► Artikel lesen | |
| 12.12.23 | OSE Immunotherapeutics - Timely FR104/VEL-101 update with Phase II plans | 344 | Edison Investment Research | OSE Immunotherapeutics (OSE) has shared a positive update on the FIRsT clinical trial assessing FR104/VEL-101 (an anti-CD28 monoclonal antibody) as a maintenance therapy for kidney transplant patients.... ► Artikel lesen | |
| 12.12.23 | discoverIE Group - Resilience from focus on strategic growth markets | 329 | Edison Investment Research | discoverIE's H124 results reflected improving profitability despite the expected lower demand due to customer destocking and the weaker economic environment. With normalisation of the order book effectively... ► Artikel lesen | |
| 12.12.23 | Vection Technologies - Established strategy to drive scalable growth | 262 | Edison Investment Research | Vection Technologies' Q124 and AGM update shows continued top-line momentum driven by an established partner strategy. Now embedded with leading players across diverse verticals, management sees an... ► Artikel lesen | |
| 12.12.23 | abrdn Asian Income Fund - Quality and value focus with an attractive yield | 258 | Edison Investment Research | abrdn Asian Income Fund (AAIF) is managed by abrdn's Singapore-based Asian equity team. As a local investor, the research team collectively speaks multiple Asian languages, so it can communicate with... ► Artikel lesen | |
| 12.12.23 | Immix Biopharma - Encouraging stream of ALA data newsflow | 322 | Edison Investment Research | Immix presented encouraging new data at the American Society of Hematology (ASH) 2023 meeting for its Nexcella subsidiary's lead CAR-T asset, NXC-201, in amyloid light chain amyloidosis (ALA) patients.... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 326 |
| BAYER | 254 |
| BYD | 171 |
| NEL | 166 |
| DEUTSCHE BANK | 162 |
| TUI | 155 |
| NVIDIA | 142 |
| TESLA | 142 |
| RHEINMETALL | 134 |
| RWE | 132 |
| PLUG POWER | 128 |
| MERCEDES-BENZ | 123 |
| APPLE | 120 |
| SUPER MICRO COMPUTER | 113 |
| DEUTSCHE LUFTHANSA | 112 |
| BERKSHIRE HATHAWAY | 109 |
| PALANTIR TECHNOLOGIES | 103 |
| XIAOMI | 97 |
| AMAZON | 95 |
| VOLKSWAGEN | 92 |
| AIXTRON SE | 90 |
| BASF | 84 |
| COMMERZBANK | 81 |
| RENK GROUP | 81 |
| SIEMENS ENERGY | 78 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
